Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

…, M Sanguinetti, S Sengupta, M Sharland… - The Lancet infectious …, 2018 - thelancet.com
Background The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity
and mortality worldwide. Due to its large public health and societal implications, multidrug-…

[HTML][HTML] Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

…, J Schnall, JAG Scott, S Seekaew, M Sharland… - The lancet, 2022 - thelancet.com
Background Antimicrobial resistance (AMR) poses a major threat to human health around
the world. Previous publications have estimated the effect of AMR on incidence, deaths, …

Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe

M Sharland, C Pulcini, S Harbarth, M Zeng… - The Lancet Infectious …, 2018 - thelancet.com
the selection and use of essential medicines. Report of the 21st WHO Expert Committee on
the Selection and Use of Essential Medicines.

Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data

…, KK Tseng, M Sharland… - The Lancet Infectious …, 2021 - thelancet.com
Background The WHO Access, Watch, and Reserve (AWaRe) antibiotic classification framework
aims to balance appropriate access to antibiotics and stewardship. We aimed to identify …

Surveillance for control of antimicrobial resistance

…, M van Mourik, A Voss, M Sharland… - The Lancet Infectious …, 2018 - thelancet.com
Antimicrobial resistance poses a growing threat to public health and the provision of health
care. Its surveillance should provide up-to-date and relevant information to monitor the …

Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart—Then Focus

D Ashiru-Oredope, M Sharland… - Journal of …, 2012 - academic.oup.com
There has been dramatic change in antibiotic use in English hospitals. Data from 2004 and
2009 show that the focus on reducing fluoroquinolone and second- and third-generation …

Potential for reducing inappropriate antibiotic prescribing in English primary care

…, DRM Smith, S Hopkins, M Sharland… - Journal of …, 2018 - academic.oup.com
Objectives To identify and quantify inappropriate systemic antibiotic prescribing in primary
care in England, and ultimately to determine the potential for reduction in prescribing of …

The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic …

…, J Bielicki, N Drapier, M Sharland… - Journal of …, 2016 - academic.oup.com
Objectives Previously, web-based tools for cross-sectional antimicrobial point prevalence
surveys (PPSs) have been used in adults to develop indicators of quality improvement. We …

Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics

…, FP Polack, O Ramilo, M Sharland… - The Lancet …, 2015 - thelancet.com
Respiratory syncytial virus (RSV) is a major worldwide cause of morbidity and mortality in
children under five years of age. Evidence-based management guidelines suggest that there is …

Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management

…, J Saavedra-Lozano, T Shah, M Sharland… - The Pediatric …, 2017 - journals.lww.com
Despite the significant long-term impact of cCMV infection, there is limited evidence on
which to base many treatment decisions in clinical practice. In an era of enhanced perinatal …